Global Blood Stream Infection Testing Market Growth (Status and Outlook) 2023-2029

Global Blood Stream Infection Testing Market Growth (Status and Outlook) 2023-2029

BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections.

LPI (LP Information)' newest research report, the “Blood Stream Infection Testing Industry Forecast” looks at past sales and reviews total world Blood Stream Infection Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Blood Stream Infection Testing sales for 2023 through 2029. With Blood Stream Infection Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Stream Infection Testing industry.

This Insight Report provides a comprehensive analysis of the global Blood Stream Infection Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Stream Infection Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Stream Infection Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Stream Infection Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Stream Infection Testing.

The global Blood Stream Infection Testing market size is projected to grow from US$ 3599.1 million in 2022 to US$ 5801.5 million in 2029; it is expected to grow at a CAGR of 7.1% from 2023 to 2029.

Bloodstream infections are mostly diagnosed by blood culture tests and molecular tests. Commercially available tests are SepsiTest, SeptiFast, MagicPlex, VYOO, and PLEX-ID. The global bloodstream infection testing market is driven by the growing incidence and prevalence of burn/wounds cases, HIV, pneumonia, pyelonephritis, and cancer. Additionally, awareness about hygiene, diagnosis rate, unhealthy lifestyle, and increase in geriatric population are the potential factors for the market growth. On the other hand, rigid regulatory scenario regarding diagnosis procedures, high diagnosis cost, and lack of medical reimbursement may hinder the growth of the market during the forecast period. Innovations, R&D investments, mergers and acquisitions among the key vendors are the dynamics for the bloodstream infection testing market to progress.  

This report presents a comprehensive overview, market shares, and growth opportunities of Blood Stream Infection Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Conventional Blood Culture Tests
PCR Methods
Nucleic Acid Testing
Mass Spectroscopy
Point of Care Testing

Segmentation by application
Hospitals
Independent Diagnostic Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
bioMérieux
Cepheid
Roche Diagnostics
IRIDICA
Bruker
Nanosphere
Siemens
AdvanDX

Please note: The report will take approximately 2 business days to prepare and deliver.